License the latest technology from Imperial College London
Technology available for licensing
Imperial College London is among the world’s leading research universities, and one of the few focused exclusively on Science, Technology, Engineering, Medicine and Business. Technology developed by Imperial’s world-leading researchers is protected and packaged by our expert commercialisation specialists.
Available technologies span all areas of research undertaken at Imperial. If your business is considering licensing technology, you can view available technologies and enquire directly through this site.
Available technologies
Browse technologies and innovations derived from research undertaken by academics at Imperial College London
Room-Temperature MASERs for Ultra-low noise devices
MASERs allow signals at microwave frequencies (0.1-100 GHz) to be amplified with unparalleled low electronic noise, allowing applications both as a receiver for deep-space communication, radar and medical imaging, and as a frequency standard for atomic clocks.
Dual-View Oblique Plane Microscopy
A novel approach to light-sheet fluorescence microscopy that uses a folded optical configuration to achieve both sample scanning and dual-view image acquisition.
Novel treatment for Huntington’s Disease using zinc finger gene therapy
A novel gene therapy for Huntington’s Disease that leverage zinc finger protein technology.
Low power nanomagnet storage and computing
A new method to change the state of individual magnetic nanoparticles within a dense array using a low cost, low-power laser for data storage technology and potential application in neuromorphic ‘in-memory’ computing.
Metal complexes for promoting growth in a photosynthetic organism
The invention A suite of novel zinc carbonic anhydrase (CA) mimics have been developed, based upon the structure of the previously published mimic ZnL1S. By changing the atoms within the ligand structure i.e. from nitrogens to sulfurs, and with various arrangements of the same or different ligands around the central metal, and thereby mimicking more […]
Catalytic materials for wastewater treatment
The invention A functional catalytic material that selectively oxidises organic molecules utilising molecular oxygen from the air is presented. The materials allow for heterogeneous reactions of molecules of interest within a liquid or in the gas phase with high yield and selectivity under mild conditions. Selective oxidation catalyst: Oxidation of bulk chemicals on a large […]
Nacre-like decorated fibre for hierarchical ductile composite
A novel nacre-like fibre coating and application method that can improve the mechanical qualities of high performance composites, enabling lightweight nanocomposites with high strength, stiffness and toughness.
Enhanced Light Extraction from Light Emitting Diodes Utilizing a Nanoparticle Meta Grid
A technique to enhance light extraction efficiency in light emitting diodes
Engine Energy Recovery via a High Efficiency Exhaust Turbine
A novel, high efficiency low pressure ratio turbine developed by engineers at Imperial College London to capture a significant portion of residual exhaust energy with negligible effect on engine base performance.
Lubricant additives to reduce fluid film friction under high pressure conditions
Novel chemical additives that reduce the fluid film friction of lubricated mechanical components under elastohydrodynamic conditions
Licensing and IP performance 2019/20
Inventions disclosed
Imperial inventors submitted 250 invention disclosures to our IPC team during the year
Active licences
Imperial College London's licensing portfolio comprises 244 licences
Patents filed
Imperial filed 137 patents (including PCT applications) during the year
Patent portfolio
Imperial's patent portfolio reached 331 patents during the year
Featured inventor
Dr Monika Reddy
Academic title - Consultant in diabetes and endocrinology
Faculty - Faculty of Medicine
Upcoming Events
Imperial.tech.pitch events – learn more and sign up
Event date - October 1, 2023
Learn about our programme of events and sign up to be alerted for future events Find out more
Latest News
Accelerated development of a potential treatment for cystic fibrosis
The UK Cystic Fibrosis Gene Therapy Consortium (GTC) is one of the partners in a licensing agreement with Boehringer Ingelheim. Find out more
Natural Killer – licensing a cell therapy
Imperial has licensed iNKT cell technology based on research by Prof. Tassos Karadimitris to SUDA Pharmaceuticals. Find out more
Imperial partner Apollo receives £100m to boost medical research at leading unis
Imperial will benefit from continued support for translational biomedical research under a unique technology transfer model. Find out more
Sign up for updates
Sign up for monthly technology alerts via email, and find other ways to connect with us.